Bicara Therapeutics Ownership | Who Owns Bicara Therapeutics?
Bicara Therapeutics Ownership Summary
Bicara Therapeutics is owned by 51.02% institutional investors, 12.16% insiders, and 36.82% retail investors. Ra capital management is the largest institutional shareholder, holding 12.75% of BCAX shares.
BCAX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bicara Therapeutics | 51.02% | 12.16% | 36.82% |
| Sector | Healthcare Stocks | 232.51% | 10.72% | -143.22% |
| Industry | Biotech Stocks | 384.55% | 10.58% | -295.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 6.96M | 12.75% | $109.84M |
| Siren | 5.22M | 9.57% | $82.38M |
| Vestal point capital, lp | 5.10M | 9.35% | $80.53M |
| Red tree management | 3.17M | 5.81% | $53.36M |
| Tpg gp a | 3.01M | 5.52% | $47.53M |
| Fmr | 2.70M | 4.95% | $42.61M |
| Blackrock funding, inc. /de | 2.53M | 4.63% | $42.55M |
| Deep track capital, lp | 2.43M | 4.45% | $38.32M |
| Omega fund management | 2.20M | 4.04% | $34.81M |
| Vanguard group | 2.19M | 4.01% | $36.79M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Red tree management | 3.17M | 48.94% | $53.36M |
| Omega fund management | 2.20M | 15.66% | $34.81M |
| Acorn capital advisors | 643.38K | 5.16% | $10.16M |
| Vestal point capital, lp | 5.10M | 3.64% | $80.53M |
| Siren | 5.22M | 3.22% | $82.38M |
| Superstring capital management lp | 175.90K | 2.74% | $2.78M |
| Tpg gp a | 3.01M | 2.59% | $47.53M |
| Aisling capital management lp | 568.92K | 2.00% | $9.57M |
| Ra capital management | 6.96M | 1.35% | $109.84M |
| Dafna capital management | 317.00K | 1.24% | $5.01M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | 1.62M | 0.01% | 1.62M |
| T. rowe price investment management | 464.73K | 0.00% | 464.73K |
| Ensign peak advisors | 401.44K | 0.01% | 401.44K |
| Goldman sachs group | 552.33K | 0.00% | 319.57K |
| Schonfeld strategic advisors | 504.08K | 0.05% | 241.33K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -2.16M |
| Deerfield management company, l.p. (series c) | - | - | -1.80M |
| Wellington management group llp | - | - | -1.39M |
| Janus henderson group | - | - | -1.34M |
| Adage capital partners gp | - | - | -1.18M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Franklin resources | 1.62M | 0.01% | 1.62M | $27.27M |
| T. rowe price investment management | 464.73K | 0.00% | 464.73K | $7.34M |
| Ensign peak advisors | 401.44K | 0.01% | 401.44K | $6.76M |
| Soleus capital management | 100.00K | 0.06% | 100.00K | $1.68M |
| Cantor fitzgerald, l. p. | 100.00K | 0.01% | 100.00K | $1.58M |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -1.00 |
| Rothschild investment | -20.00 |
| Mrp capital investments | -20.00 |
| Signaturefd | -80.00 |
| Kessler investment group | -200.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 92 | -19.30% | 27,836,301 | -44.55% | 51 | 0.60% | 57 | -12.31% | 23 | -14.81% |
| Sep 30, 2025 | 111 | 5.71% | 49,553,927 | -3.15% | 90 | 1.03% | 64 | -18.99% | 26 | 62.50% |
| Jun 30, 2025 | 105 | 19.32% | 51,165,429 | 15.59% | 93 | 1.42% | 79 | 46.30% | 16 | - |
| Mar 31, 2025 | 92 | 13.58% | 48,567,553 | 4.69% | 89 | 1.23% | 54 | -10.00% | 18 | 157.14% |
| Dec 31, 2024 | 83 | 22.06% | 46,705,507 | 28.51% | 85 | 1.92% | 62 | -8.82% | 7 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 22, 2026 | Cohlhepp Ryan | President and COO | Sell | $69.30K |
| Jan 22, 2026 | Hyep Ivan | Chief Financial Officer | Sell | $34.16K |
| Jan 15, 2026 | Cohlhepp Ryan | President and COO | Sell | $2.68K |
| Dec 22, 2025 | Hyep Ivan | Chief Financial Officer | Sell | $168.49K |
| Dec 15, 2025 | Cohlhepp Ryan | President and COO | Sell | $84.08K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 23 |
| 2025 Q3 | - | 2 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 2 |
BCAX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools